AUG 3, 2026 · PHASE 3 TRIAL
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
ClinicalTrials.gov
This is an active Phase 3 RCT registration with no posted results; the study design and planned enrollment are reported but outcomes remain unknown.
Reported
Planned enrollment330
PhasePHASE 3
Primary outcome measureRelative change in body weight from baselin…